This page shows you the latest news items in this category. This is page number 10.

Total 28066 results found since Jan 2013.

Endocrine Dysfunction From Immune Checkpoint Inhibitors Endocrine Dysfunction From Immune Checkpoint Inhibitors
Immune checkpoint inhibitors are used in the treatment of various types of cancers, but can lead to endocrine-related toxicities. How are these adverse events best managed?Journal of Oncology Practice
Source: Medscape General Surgery Headlines - August 22, 2023 Category: Surgery Tags: Hematology-Oncology Journal Article Source Type: news

FDA Approves the First RSV Vaccine for Pregnant Women
The US Food and Drug Administration (FDA) today (Aug. 21) approved the first vaccine for respiratory syncytial virus (RSV) for pregnant women, which is designed to protect newborns from the infection. The shot becomes the second RSV vaccine, and third new intervention against the disease this year. In May, the FDA approved the Abrysvo vaccine for preventing RSV in people 60 years and older. The same vaccine is now approved for pregnant people in their third trimester. And in July, the agency approved nirsevimab, an antibody-based injection that protects babies immediately after birth from RSV. [time-brightcove not-tgx=&...
Source: TIME: Health - August 21, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Vaccines Source Type: news

T-Cell Tolerant Fraction Can Predict Immunotherapy Toxicity
MONDAY, Aug. 21, 2023 -- The T-cell tolerant fraction predicts clinically significant immune-related adverse events (irAEs) among patients with cancer treated with immune checkpoint inhibitors (ICIs), according to a study published in the August...
Source: Drugs.com - Pharma News - August 21, 2023 Category: Pharmaceuticals Source Type: news

magAssist's NyokAssist(TM) granted Designation by the FDA as a Breakthrough Device
SUZHOU, China, Aug. 21, 2023 -- (Healthcare Sales & Marketing Network) -- Recently, magAssist's NyokAssist™ Interventional Ventricular Assist Device (hereinafter referred to as NyokAssist™), has been granted designation as a breakthrough device by the U.S... Devices, Interventional, Cardiology, FDA magAssist, NyokAssist, interventional VAD
Source: HSMN NewsFeed - August 21, 2023 Category: Pharmaceuticals Source Type: news

Fulfilling the rights of victims of domestic violence (study at Aru Islands Police) - Djilarpoin DS, Adam S.
Introductioan: Victims of domestic violence can exercise their rights as mandated in the PKDRT Law so that they can assist the police in smoothing the legal process that is handled and cooperation between the Police and related agencies and the victims the...
Source: SafetyLit - August 21, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Harvard gut doctor shares 4 foods that cause inflammation
Inflammation is an essential process that increases blood flow to an infected area of the body, and carries in immune system cells to heal it. But it can be uncomfortable, and chronic inflammation can damage healthy cells while creating a series of unpleasant symptoms such as joint stiffness,…#harvardmedicalschool
Source: Reuters: Health - August 19, 2023 Category: Consumer Health News Source Type: news

Financial Success Can Uncover Limiting Beliefs About Money For Some
As a financial coach and consultant, I provide education around the intersection of money and mental health from the position of an expert. My expertise however doesn’t make me immune to the very things I discuss such as: Experiencing these things is as normal as breathing and in many ways by…
Source: Reuters: Health - August 19, 2023 Category: Consumer Health News Source Type: news

Ultra-Rare Immune System Disease Gets First FDA-Approved Treatment
(MedPage Today) -- The FDA approved pozelimab (Veopoz) as the first treatment for adults and children ages 1 year and up with CD55-deficient protein-losing enteropathy. Also known as CHAPLE (complement hyperactivation, angiopathic thrombosis...
Source: MedPage Today Gastroenterology - August 18, 2023 Category: Gastroenterology Source Type: news

Recall for Impella RP Flex Labeling Short on Safety Cautions Recall for Impella RP Flex Labeling Short on Safety Cautions
The FDA says medical device manufacturer Abiomed has voluntarily recalled labeling that ' s short on safety information for one model in its line of circulatory-assist pumps.Medscape Medical News
Source: Medscape Cardiology Headlines - August 18, 2023 Category: Cardiology Tags: Cardiology News Alert Source Type: news

How COVID-19 Changes the Immune System
If the COVID-19 pandemic has done one thing, it’s made us all more familiar with some of the important players in the immune system. Antibodies, B cells, and T cells are among the best known parts of the body’s response to a virus like SARS-CoV-2, but they don’t act alone. In a paper published on August 18 in the journal Cell, scientists report that innate immune cells—a critical part of the immune system activated to battle COVID-19—remain altered for at least a year after infection. The finding suggests that these cells may play a role in some of the lingering symptoms associated with Lon...
Source: TIME: Health - August 18, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Severe COVID-19 may lead to long-term innate immune system changes
NIH-funded research links alterations to inflammatory protein, underscores vaccine importance.
Source: National Institutes of Health (NIH) News Releases - August 18, 2023 Category: American Health Source Type: news

Moderna says new Covid vaccine was effective against Eris variant in early trial
Moderna's new Covid vaccine generated a robust immune response against the now-dominant Eris variant and another rapidly spreading strain of the virus in an early clinical trial, the biotech company said Thursday. The updated shot is designed to target omicron subvariant XBB.1.5, but the results…#fornax #pfizer #fl #cdc
Source: Reuters: Health - August 18, 2023 Category: Consumer Health News Source Type: news

Teeth could preserve antibodies hundreds of years old, study finds
Teeth could be capable of preserving antibodies for hundreds of years, allowing scientists to investigate the history of infectious human diseases, a new study has found.Antibodies are proteins produced by the immune system as a natural response to infectious organisms like viruses and bacteria. Their job is to recognise those microbes so that the immune system can attack them and clear them from the body.In the new paper, published by iScience, antibodies extracted from 800 year-old medieval human teeth were found to be stable and still able to recognise viral proteins.The study, led by Professor Robert Layfield and ...
Source: Dental Technology Blog - August 17, 2023 Category: Dentistry Source Type: news

The people found to be most at risk of Covid - new study as Eris variant emerges
Covid vaccinations are meant to prompt the immune system to produce antibodies against coronavirus, but this may not work for everybody.
Source: Daily Express - Health - August 17, 2023 Category: Consumer Health News Source Type: news

Traffic incident management performance measures: ranking agencies on roadway clearance time - Mumtarin M, Knickerbocker S, Litteral T, Wood JS.
This study develops a procedure to rank agencies based on their incident responses using roadway clearance times for crashes. This analysis is not intended to grade agencies but to assist in identifying agencies requiring more training or resources for inc...
Source: SafetyLit - August 17, 2023 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news